ArticleHealth science reports2026
The Effect of N-Acetyl Cysteine on Serum Lipid Profile and Heavy Metals in Women With Endometriosis Undergoing ICSI: A Randomized Controlled Trial.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Endometriosis is associated with oxidative stress and heavy metal accumulation. This study evaluated whether N-acetylcysteine (NAC) reduces serum heavy metals and improves lipid profiles in women with endometriosis undergoing fertility treatment. Methods: In this randomized controlled trial, 60 women with laparoscopy-confirmed endometriosis were allocated to NAC (1.8-3 g/day, increased to 3 g/day in participants with BMI ≥ 25 kg/m) or control groups for 6 weeks. Serum levels of lead, cadmium, nickel, chromium, and lipid profiles were measured using atomic absorption spectroscopy and enzymatic assays. Primary outcomes were heavy metal changes; secondary outcomes were lipid profile alterations. Results: Baseline characteristics were comparable between groups. After 6 weeks, NAC significantly reduced serum lead (MD -0.6 μg/dL; Cohen's d = 0.62; Conclusion: NAC supplementation was associated with reduced serum lead and nickel concentrations and improved lipid parameters in women with endometriosis undergoing ICSI. However, the observed reduction in HDL cholesterol warrants cautious interpretation, and further studies are required to confirm these findings and clarify their clinical significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.